INDICATION

Dolgenal (Ketorolac Tromethamine) tablets are indicated for the short-term management of moderate to severe acute postoperative pain.

DOSAGE & ADMINISTRATION

Dolgenal (Ketorolac Tromethamine) tablets are recommended for short-term use only (up to 7 days) and are not recommended for chronic use.

Adults: 10 mg every 4 to 6 hours as required. Doses exceeding 40 mg per day are not recommended. Opioid analgesics are required for optimal analgesic effect in the early postoperative period when pain is most severe. Ketorolac does not interfere with opioid binding and does not exacerbate opioid-related respiratory depression or sedation. For patients receiving parenteral Ketorolac Tromethamine and who are converted to Ketorolac Tromethamine oral tablets, the total combined daily dose should not exceed 90 mg (60 mg for elderly, renally-impaired patients and patients less than 50 kg) and the oral component should not exceed 40 mg on the day the change of formulation is made. Patients should be converted to oral treatment as soon as possible. Elderly: A longer dosing interval, e.g. 6-8 hourly, is advisable in the elderly. The lower end of the dosage range is recommended for patients over 65 years of age.

Children: Ketorolac Tromethamine is not recommended for use in children under 16 years of age. 

FIND A PRODUCT